Research map: Integrating a biopsychosocial perspective: WHODAS 2.0 enhances functioning assessment in Parkinson's disease
Back to the article
Papers in this map
An Inventory for Measuring Depression
· Aaron T. Beck · 1961 · 38426 citations · Cited by this paper
A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms
· 2025 · Related
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
· Erik B von Elm · 2007 · 20683 citations · Cited by this paper
A review of FDG-PET biomarker analysis methods in Parkinson's disease
· 2026 · Related
Parkinsonism
· Margaret M. Maier Hoehn · 1967 · 12189 citations · Cited by this paper
Effects of deep brain stimulation on functional autonomy and quality of life in Parkinson's disease: A systematic review and meta-analysis
· 2026 · Related
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
· Andrew Jerome Hughes · 1992 · 10509 citations · Cited by this paper
Association between age at Parkinson's disease onset and divorce: An exploratory analysis from the fox insight cohort
· 2026 · Related
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results
· Christopher G. Goetz · 2008 · 7797 citations · Cited by this paper
Continuous apomorphine infusion modulates cortical hyperexcitability and abnormal plasticity in Parkinson's disease
· 2026 · Related
MDS clinical diagnostic criteria for Parkinson's disease
· Ronald B. Postuma · 2015 · 7781 citations · Cited by this paper
Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape
· 2026 · Related
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
· E. Ray Dorsey · 2018 · 2883 citations · Cited by this paper
Cognition endpoints for Parkinson's disease: A roadmap for developing patient-focused assessment tools to accelerate drug development
· 2026 · Related
Developing the World Health Organization Disability Assessment Schedule 2.0
· T. Bedirhan Üstün · 2010 · 1893 citations · Cited by this paper
Gut microbiome dysbiosis, short-chain fatty acid depletion and implications for neuroinflammation in atypical parkinsonian syndromes – a systematic review of patient cohorts
· 2026 · Related
World Health Organization disability assessment schedule 2.0: An international systematic review
· Stefano Federici · 2016 · 524 citations · Cited by this paper
Aligning incentives for open science in biomedical research: Navigating funder and institutional perspectives
· 2025 · Related
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
· Stefanie Theresa Jost · 2023 · 393 citations · Cited by this paper
Prevalence and related factors of blood pressure regulation abnormalities in Parkinson's disease: Orthostatic hypotension and supine hypertension
· 2025 · Related
The evolution of disability in Parkinson disease
· Lisa M. Shulman · 2008 · 299 citations · Cited by this paper
Progression of motor impairment and disability in Parkinson disease
· Guido Werner Alves · 2005 · 273 citations · Cited by this paper
Late-stage Parkinson disease
· Miguel M Coelho · 2012 · 253 citations · Cited by this paper
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
· Ying Jiao Zhao · 2010 · 218 citations · Cited by this paper
Burden, perceived health status, and mood among caregivers of Parkinson's disease patients
· Pablo Martínez‐Martín · 2008 · 204 citations · Cited by this paper
Rate of clinical progression in Parkinson's disease. A prospective study
· Anette E. Schrag · 2007 · 171 citations · Cited by this paper
Communication impairment in Parkinson’s disease: Impact of motor and cognitive symptoms on speech and language
· Kara M. Smith · 2018 · 150 citations · Cited by this paper
Validation of the MDS‐UPDRS Part I for nonmotor symptoms in Parkinson's disease
· David A. Gallagher · 2011 · 134 citations · Cited by this paper
Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries
· Katia Noyes · 2005 · 133 citations · Cited by this paper
CRITÉRIOS DE ESTRATIFICAÇÃO E COMPARAÇÃO DE CLASSIFICADORES SOCIOECONÔMICOS NO BRASIL
· Wagner A. Kamakura · 2016 · 124 citations · Cited by this paper
Caregiver burden and family functioning in different neurological diseases
· Francesco Tramonti · 2018 · 114 citations · Cited by this paper
Measuring participation in individuals with Parkinson disease: relationships with disease severity, quality of life, and mobility
· Ryan P. Duncan · 2010 · 102 citations · Cited by this paper
Clinical measures of progression in Parkinson's disease
· Werner H Poewe · 2009 · 100 citations · Cited by this paper
The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease
· Carmen Rodríguez‐Blázquez · 2013 · 90 citations · Cited by this paper
Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning
· Anat Mirelman · 2021 · 90 citations · Cited by this paper
Social withdrawal in Parkinson's disease: A scoping review
· Soojung Ahn · 2022 · 75 citations · Cited by this paper
Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study
· Yaroslav Winter · 2009 · 66 citations · Cited by this paper
Relationship between the MDS‐UPDRS domains and the health‐related quality of life of P arkinson's disease patients
· Pablo Martínez‐Martín · 2014 · 62 citations · Cited by this paper
Socioeconomic status in relation to Parkinson's disease risk and mortality
· Yang Fei · 2016 · 61 citations · Cited by this paper
Source: OpenAlex (CC0)